You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ATYR Award Disclosure
Yaras Brandon · SEC Form 4 · Filed Oct 1, 2026
Award
Calculated transaction value
$0
Yaras Brandon Chief Financial Officer
ATYR
aTyr Pharma
ATYR
Transaction date
Oct 1, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed same day
ATYR daily price context
Close on/before transaction
$0.29
Oct 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 410,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002156611-26-000010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Atyr Pharma Inc ATYR Current | Award | Oct 1, 2026 | $0 |